Teriparatide
Teriparatide is a pharmaceutical drug with 109 clinical trials. Currently 8 active trials ongoing. Historical success rate of 90.8%.
Success Metrics
Based on 79 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
24
Mid Stage
60
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.8%
79 of 90 finished
12.2%
11 ended early
8
trials recruiting
109
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combined Anabolic Therapy
Precision Medicine Approach for Osteoporosis - Follow Up Study
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Clinical Trials (109)
Combined Anabolic Therapy
Precision Medicine Approach for Osteoporosis - Follow Up Study
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis
Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging
Sequential Therapies After Osteoanabolic Treatment
Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
Teriparatide on Maxillary Sinus Floor Osseointegration
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
Replication of the VERO Osteoporosis Trial in Healthcare Claims Data
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Teriparatide as a Chondroregenerative Therapy in OA
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 109